awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38044736-6EC2EC95-BBD0-45D1-84BC-20F4003DAD21
Q38044736-6EC2EC95-BBD0-45D1-84BC-20F4003DAD21
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38044736-6EC2EC95-BBD0-45D1-84BC-20F4003DAD21
JAK2 inhibitors in the treatment of myeloproliferative neoplasms.
P2860
Q38044736-6EC2EC95-BBD0-45D1-84BC-20F4003DAD21
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38044736-6EC2EC95-BBD0-45D1-84BC-20F4003DAD21
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27279a8997fad3a03fc6cc5c9956c87edeb8b04a
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.